Asker Healthcare Group AB (OSTO:ASKER) Marketable Securities: kr0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ASKER Asker Healthcare Group AB OSTO:ASKER
13 GF Score
Price kr78.65
! 2 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB Marketable Securities?

Asker Healthcare Group AB OSTO:ASKER +1.03% 13 Marketable Securities is kr0 Mil as of Jun. 2026. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Asker Healthcare Group AB's Marketable Securities for the quarter that ended in Jun. 2026 was kr0 Mil.

Asker Healthcare Group AB  (OSTO:ASKER) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Asker Healthcare Group AB Marketable Securities Related Terms

Asker Healthcare Group AB Marketable Securities Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB Marketable Securities Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
0.00 0.00 0.00 0.00

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:ASKER
13GF Score
Asker Healthcare Group AB OSTO:ASKER
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of kr0 Mil mean?
Asker Healthcare Group AB (OSTO:ASKER) has a Marketable Securities of kr0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Asker Healthcare Group AB and its competitors.
Is Asker Healthcare Group AB's Marketable Securities too high?
Asker Healthcare Group AB's current Marketable Securities is kr0 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Marketable Securities compare to MCK and CAH?
Asker Healthcare Group AB's Marketable Securities of kr0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current Marketable Securities is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current Marketable Securities of kr0 Mil. The current Marketable Securities is kr0 Mil. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current Marketable Securities is kr0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKERs:UKI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score

Get the complete analysis for OSTO:ASKER

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr78.65
Price